As President Trump prepares to meet Chinese leader Xi Jinping in a high-stakes attempt to ease renewed trade tensions, another front in America’s economic rivalry with China is emerging: the race for global biotech leadership. Just as U.S. leadership in shipbuilding and semiconductors slipped away in past decades, the country now risks ceding biomedical innovation to China at the very moment when biotech defines both national strength and health security.
When looking at the past century, a clear pattern has emerged of the U.S. rising as the manufacturing star of essential goods, only to hand the business to China. We’ve seen it with shipbuilding. We’ve seen it with semiconductors. And it’s currently happening with biomedical research.
STAT Pharma: The science and business of new drug development
Leave a Reply